Prostatic intraepithelial neoplasia (PIN) is the most widely accepted precursor lesion for prostate cancer, representing neoplastic transformation of acinar and ductal epithelial cells of the prostate gland. Histologically classified into low-grade (LGPIN) and high-grade (HGPIN), the clinically and radiologically significant form is HGPIN. HGPIN is characterized by epithelial cells showing dysplastic changes without disruption of the basal membrane (no invasion) in prostatic acini and ducts. Prevalence is reported as 16-40% in autopsy series and increases with age. On mpMRI, PIN typically presents as subtle T2 hypointensity in the peripheral zone and can be difficult to distinguish from adenocarcinoma; however, it typically shows less pronounced diffusion restriction on DWI compared to adenocarcinoma, with ADC values positioned between normal and adenocarcinoma. PI-RADS v2.1 does not define PIN as a specific category, but suspicious findings are assessed in PI-RADS 3 (equivocal) category. When HGPIN is detected on systematic biopsy, the risk of concurrent adenocarcinoma in the same or contralateral lobe is 20-30%, and repeat biopsy within 12 months is recommended. Isolated LGPIN is clinically insignificant and requires no additional follow-up.
Age Range
50-75
Peak Age
65
Gender
Male predominant
Prevalence
Uncommon
PIN represents the intermediate step in the multistep carcinogenesis pathway from normal epithelium to invasive carcinoma of prostatic acinar and ductal epithelium. The anticipated progression model is normal prostate epithelium → LGPIN → HGPIN → invasive adenocarcinoma. At the cellular level, HGPIN shows marked nuclear atypia (large, pleomorphic nucleus, prominent nucleolus), increased mitotic activity, and loss of cellular polarity, while the basal cell layer remains preserved — this is the fundamental difference from invasive adenocarcinoma. At the genetic level, molecular changes specific to prostate cancer such as TMPRSS2-ERG fusion, PTEN loss, and telomere shortening are also detected in HGPIN, supporting its precursor status. On MRI, subtle hypointensity on T2-weighted sequences reflects disruption in cellular organization while dysplastic epithelium partially preserves normal glandular architecture — since glandular lumens containing free fluid that create the high T2 signal of the normal peripheral zone are partially preserved, T2 decrease is not as marked as in adenocarcinoma. Mild to moderate diffusion restriction on DWI reflects increased cellular density but not as dense as in adenocarcinoma.
The characteristic finding is that ADC values of PIN are positioned in the 'gray zone' (1.0-1.3 × 10⁻³ mm²/s) between normal peripheral zone and adenocarcinoma. This gray zone ADC value reflects that the density of dysplastic cells is greater than normal tissue but less than adenocarcinoma. When gray zone ADC is detected in lesions assessed as PI-RADS 3, the probability of HGPIN should be increased.
Observed as subtle hypointensity in the peripheral zone on T2-weighted sequences. Shows mild signal decrease compared to the homogeneous high T2 signal of the normal peripheral zone, but not as conspicuous as the marked focal hypointensity seen in adenocarcinoma. Lesion margins are typically indistinct and poorly defined. Multifocal involvement may occur. Identifying PIN in the transition zone is very difficult against the already heterogeneous background of BPH.
Report Sentence
A subtle area of T2 hypointensity is identified in the [location] of the peripheral zone of the prostate, and precursor lesion such as prostatic intraepithelial neoplasia should be considered in the differential diagnosis.
Shows mild to moderate diffusion restriction on DWI. Signal decrease on ADC map may be detected but is not as dramatic as the marked ADC decrease in adenocarcinoma. ADC values are typically between 1.0-1.3 × 10⁻³ mm²/s, creating a 'gray zone' between normal peripheral zone (1.4-1.8 × 10⁻³ mm²/s) and adenocarcinoma (0.6-1.0 × 10⁻³ mm²/s). Due to this overlap, DWI/ADC alone is insufficient for PIN-adenocarcinoma differentiation.
Report Sentence
Mild to moderate diffusion restriction is observed on DWI in the subtle T2-hypointense area in the peripheral zone (ADC value: [value] × 10⁻³ mm²/s), which may be consistent with prostatic intraepithelial neoplasia or low-grade tumor.
On dynamic contrast-enhanced MRI (DCE), mild early enhancement may be observed but this finding is typically not conspicuous as a focal lesion. Capillary permeability in PIN areas may be slightly increased compared to normal prostate tissue. DCE is used as an ancillary criterion in PI-RADS v2.1 for peripheral zone lesions (can upgrade PI-RADS 3 to 4) but is insufficient for PIN-adenocarcinoma differentiation as both may show early enhancement.
Report Sentence
Mild early enhancement is observed in the area of interest on DCE sequences, considered as an ancillary criterion in PI-RADS assessment.
Prostate zonal anatomy is generally preserved in PIN. The peripheral zone-transition zone boundary (surgical capsule) is not disrupted. Although subtle hypointensity on T2 is focal, it does not disrupt zonal architecture and does not create mass effect. This feature is a helpful finding in differentiation from adenocarcinoma which disrupts zonal anatomy and creates mass effect. Multifocal subtle changes may be seen bilaterally in the peripheral zone.
Report Sentence
Prostate zonal anatomy is preserved, and the subtle T2 hypointensity does not disrupt zonal architecture.
May be observed as a subtle hypoechoic focus in the peripheral zone on TRUS, but most PIN lesions are not visible on TRUS. When visible, it is indistinguishable from the classic hypoechoic lesion of adenocarcinoma. TRUS sensitivity for PIN detection is low (15-30%). During systematic biopsy, targeted biopsy from hypoechoic areas under TRUS guidance is performed for echosonically suspicious lesions.
Report Sentence
A subtle hypoechoic focus is identified in the [location] of the peripheral zone on TRUS, and targeted biopsy is recommended.
Criteria
Characterized by marked nuclear atypia (large, pleomorphic nucleus, prominent nucleolus), increased mitotic activity, loss of cellular polarity. Basal cell layer preserved. Risk of progression to prostate cancer is 20-30%.
Distinct Features
May show subtle but detectable T2 hypointensity on mpMRI. Mild to moderate diffusion restriction on DWI. Gray zone ADC values. Repeat biopsy within 12 months recommended. Multifocal HGPIN further increases concurrent cancer risk. Basal cell preservation demonstrated with p63/CK5/6 immunohistochemistry.
Criteria
Mild nuclear atypia, basal cell layer completely preserved. Considered clinically insignificant. No additional biopsy or follow-up required. Difficult to distinguish from normal prostatic tissue.
Distinct Features
Undetectable on mpMRI — produces no imaging findings. Diagnosis is purely histopathological. Cancer progression risk is negligible. Standard routine PSA follow-up is sufficient for patients receiving LGPIN report.
Criteria
Detection of ASAP together with HGPIN constitutes the highest risk category. ASAP alone carries 40-60% cancer risk, and coexistence with HGPIN further increases the risk. Repeat biopsy within 3-6 months is mandatory.
Distinct Features
More pronounced T2 hypointensity and DWI restriction may accompany on mpMRI. Indication for MR-guided targeted biopsy is strengthened. HGPIN+ASAP coexistence is more frequently detected in lesions assessed as PI-RADS 3-4.
Distinguishing Feature
In adenocarcinoma, marked focal hypointensity on T2 and sharply defined mass effect are seen, while in PIN subtle and poorly defined hypointensity does not disrupt zonal anatomy. Adenocarcinoma shows marked diffusion restriction on DWI (ADC <1.0 × 10⁻³ mm²/s), while PIN shows gray zone ADC values. Adenocarcinoma is assessed as PI-RADS 4-5, PIN typically as PI-RADS 3. Definitive differentiation can only be made by biopsy.
Distinguishing Feature
In chronic prostatitis, band-like or diffuse hypointensity in the peripheral zone is seen on T2, while PIN tends to show more focal involvement. Prostatitis may show mild diffusion restriction on DWI and ADC values can overlap with PIN. Clinical context differs: prostatitis is symptomatic (pain, dysuria) while PIN is asymptomatic. If focal lesion disappears in an area thought to be prostatitis after biopsy, it favors prostatitis.
Distinguishing Feature
In atrophy, wedge-shaped or linear hypointensity is seen on T2 without significant diffusion restriction on DWI (ADC normal). In PIN, more round/focal hypointensity and mild DWI restriction may be present. Atrophy is generally accompanied by volume loss, PIN does not show volume loss. Both are known as cancer mimics but their mechanisms and prognostic significance differ.
Urgency
surveillanceManagement
surveillanceBiopsy
NeededFollow-up
12-monthHGPIN is the most important precursor lesion of prostate cancer, and when detected on systematic biopsy, the risk of concurrent adenocarcinoma is 20-30%. Clinical management: (1) Isolated HGPIN (single focus, ≤2 cores): repeat systematic biopsy within 12 months; (2) Extensive HGPIN (≥3 cores or bilateral): repeat biopsy within 6-12 months + mpMRI indication; (3) HGPIN + ASAP: repeat biopsy within 3-6 months mandatory (high cancer risk); (4) LGPIN: clinically insignificant, no additional follow-up needed. PI-RADS 3 lesions on mpMRI may be harbingers of HGPIN — targeted sampling with MR-guided biopsy is recommended. Active treatment (prostatectomy, radiotherapy) is not indicated for HGPIN; managed with surveillance and repeat biopsy strategy. PSA monitoring should continue — PSA elevation may indicate concurrent cancer.
HGPIN is considered a premalignant lesion for prostate cancer. When HGPIN is detected on biopsy, there is a 20-30% risk of concomitant cancer. Follow-up biopsy (6-12 months) and close monitoring with mpMRI are recommended. PIN alone does not require treatment.